Global Induced Pluripotent Stem Cells (iPSCs) Market Growth (Status and Outlook) 2025-2031

January 2025 | 83 pages | ID: GE3E69947E3EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

The global Induced Pluripotent Stem Cells (iPSCs) market size is predicted to grow from US$ 125 million in 2025 to US$ 257 million in 2031; it is expected to grow at a CAGR of 12.8% from 2025 to 2031.

Induced pluripotent stem cells (also known as iPS cells or iPSCs) are a type of pluripotent stem cell that can be generated directly from adult cells. The opportunities concerning a wide range of diseases including neurodegenerative, metabolic and cardiovascular diseases in a dish for cheaper and faster drug discovery. This may be particularly important in the context of monogenic rare hereditary diseases, where iPSCs can provide an alternative model system to compensate for the lack of a predictive in-vitro human model for drug discovery.

United States is the largest Induced Pluripotent Stem Cells (iPSCs) market with about 43% market share. Europe is follower, accounting for about 33% market share.

The key players are Fujifilm Holding Corporation (CDI), Ncardia, Sumitomo Dainippon Pharma, Astellas Pharma Inc, Fate Therapeutics, Inc, Pluricell Biotech, Cell Inspire Biotechnology, ReproCELL etc. Top 3 companies occupied about 73% market share.

LPI (LP Information)' newest research report, the “Induced Pluripotent Stem Cells (iPSCs) Industry Forecast” looks at past sales and reviews total world Induced Pluripotent Stem Cells (iPSCs) sales in 2024, providing a comprehensive analysis by region and market sector of projected Induced Pluripotent Stem Cells (iPSCs) sales for 2025 through 2031. With Induced Pluripotent Stem Cells (iPSCs) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Induced Pluripotent Stem Cells (iPSCs) industry.

This Insight Report provides a comprehensive analysis of the global Induced Pluripotent Stem Cells (iPSCs) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Induced Pluripotent Stem Cells (iPSCs) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Induced Pluripotent Stem Cells (iPSCs) market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Induced Pluripotent Stem Cells (iPSCs) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Induced Pluripotent Stem Cells (iPSCs).

This report presents a comprehensive overview, market shares, and growth opportunities of Induced Pluripotent Stem Cells (iPSCs) market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Human iPSCs
• Mouse iPSCs

Segmentation by Application:

• Academic Research
• Drug Development and Discovery
• Toxicity Screening
• Regenerative Medicine
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Fujifilm Holding Corporation (CDI)
• Ncardia
• Sumitomo Dainippon Pharma
• Astellas Pharma Inc
• Fate Therapeutics, Inc
• Pluricell Biotech
• Cell Inspire Biotechnology
• ReproCELL

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Induced Pluripotent Stem Cells (iPSCs) Market Size (2020-2031)
  2.1.2 Induced Pluripotent Stem Cells (iPSCs) Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Induced Pluripotent Stem Cells (iPSCs) by Country/Region (2020, 2024 & 2031)
2.2 Induced Pluripotent Stem Cells (iPSCs) Segment by Type
  2.2.1 Human iPSCs
  2.2.2 Mouse iPSCs
2.3 Induced Pluripotent Stem Cells (iPSCs) Market Size by Type
  2.3.1 Induced Pluripotent Stem Cells (iPSCs) Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Type (2020-2025)
2.4 Induced Pluripotent Stem Cells (iPSCs) Segment by Application
  2.4.1 Academic Research
  2.4.2 Drug Development and Discovery
  2.4.3 Toxicity Screening
  2.4.4 Regenerative Medicine
  2.4.5 Others
2.5 Induced Pluripotent Stem Cells (iPSCs) Market Size by Application
  2.5.1 Induced Pluripotent Stem Cells (iPSCs) Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Application (2020-2025)

3 INDUCED PLURIPOTENT STEM CELLS (IPSCS) MARKET SIZE BY PLAYER

3.1 Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Player
  3.1.1 Global Induced Pluripotent Stem Cells (iPSCs) Revenue by Player (2020-2025)
  3.1.2 Global Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Player (2020-2025)
3.2 Global Induced Pluripotent Stem Cells (iPSCs) Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 INDUCED PLURIPOTENT STEM CELLS (IPSCS) BY REGION

4.1 Induced Pluripotent Stem Cells (iPSCs) Market Size by Region (2020-2025)
4.2 Global Induced Pluripotent Stem Cells (iPSCs) Annual Revenue by Country/Region (2020-2025)
4.3 Americas Induced Pluripotent Stem Cells (iPSCs) Market Size Growth (2020-2025)
4.4 APAC Induced Pluripotent Stem Cells (iPSCs) Market Size Growth (2020-2025)
4.5 Europe Induced Pluripotent Stem Cells (iPSCs) Market Size Growth (2020-2025)
4.6 Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2020-2025)
5.2 Americas Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2020-2025)
5.3 Americas Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Induced Pluripotent Stem Cells (iPSCs) Market Size by Region (2020-2025)
6.2 APAC Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2020-2025)
6.3 APAC Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2020-2025)
7.2 Europe Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2020-2025)
7.3 Europe Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) by Region (2020-2025)
8.2 Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2020-2025)
8.3 Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL INDUCED PLURIPOTENT STEM CELLS (IPSCS) MARKET FORECAST

10.1 Global Induced Pluripotent Stem Cells (iPSCs) Forecast by Region (2026-2031)
  10.1.1 Global Induced Pluripotent Stem Cells (iPSCs) Forecast by Region (2026-2031)
  10.1.2 Americas Induced Pluripotent Stem Cells (iPSCs) Forecast
  10.1.3 APAC Induced Pluripotent Stem Cells (iPSCs) Forecast
  10.1.4 Europe Induced Pluripotent Stem Cells (iPSCs) Forecast
  10.1.5 Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Forecast
10.2 Americas Induced Pluripotent Stem Cells (iPSCs) Forecast by Country (2026-2031)
  10.2.1 United States Market Induced Pluripotent Stem Cells (iPSCs) Forecast
  10.2.2 Canada Market Induced Pluripotent Stem Cells (iPSCs) Forecast
  10.2.3 Mexico Market Induced Pluripotent Stem Cells (iPSCs) Forecast
  10.2.4 Brazil Market Induced Pluripotent Stem Cells (iPSCs) Forecast
10.3 APAC Induced Pluripotent Stem Cells (iPSCs) Forecast by Region (2026-2031)
  10.3.1 China Induced Pluripotent Stem Cells (iPSCs) Market Forecast
  10.3.2 Japan Market Induced Pluripotent Stem Cells (iPSCs) Forecast
  10.3.3 Korea Market Induced Pluripotent Stem Cells (iPSCs) Forecast
  10.3.4 Southeast Asia Market Induced Pluripotent Stem Cells (iPSCs) Forecast
  10.3.5 India Market Induced Pluripotent Stem Cells (iPSCs) Forecast
  10.3.6 Australia Market Induced Pluripotent Stem Cells (iPSCs) Forecast
10.4 Europe Induced Pluripotent Stem Cells (iPSCs) Forecast by Country (2026-2031)
  10.4.1 Germany Market Induced Pluripotent Stem Cells (iPSCs) Forecast
  10.4.2 France Market Induced Pluripotent Stem Cells (iPSCs) Forecast
  10.4.3 UK Market Induced Pluripotent Stem Cells (iPSCs) Forecast
  10.4.4 Italy Market Induced Pluripotent Stem Cells (iPSCs) Forecast
  10.4.5 Russia Market Induced Pluripotent Stem Cells (iPSCs) Forecast
10.5 Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Forecast by Region (2026-2031)
  10.5.1 Egypt Market Induced Pluripotent Stem Cells (iPSCs) Forecast
  10.5.2 South Africa Market Induced Pluripotent Stem Cells (iPSCs) Forecast
  10.5.3 Israel Market Induced Pluripotent Stem Cells (iPSCs) Forecast
  10.5.4 Turkey Market Induced Pluripotent Stem Cells (iPSCs) Forecast
10.6 Global Induced Pluripotent Stem Cells (iPSCs) Forecast by Type (2026-2031)
10.7 Global Induced Pluripotent Stem Cells (iPSCs) Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Induced Pluripotent Stem Cells (iPSCs) Forecast

11 KEY PLAYERS ANALYSIS

11.1 Fujifilm Holding Corporation (CDI)
  11.1.1 Fujifilm Holding Corporation (CDI) Company Information
  11.1.2 Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells (iPSCs) Product Offered
  11.1.3 Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells (iPSCs) Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Fujifilm Holding Corporation (CDI) Main Business Overview
  11.1.5 Fujifilm Holding Corporation (CDI) Latest Developments
11.2 Ncardia
  11.2.1 Ncardia Company Information
  11.2.2 Ncardia Induced Pluripotent Stem Cells (iPSCs) Product Offered
  11.2.3 Ncardia Induced Pluripotent Stem Cells (iPSCs) Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Ncardia Main Business Overview
  11.2.5 Ncardia Latest Developments
11.3 Sumitomo Dainippon Pharma
  11.3.1 Sumitomo Dainippon Pharma Company Information
  11.3.2 Sumitomo Dainippon Pharma Induced Pluripotent Stem Cells (iPSCs) Product Offered
  11.3.3 Sumitomo Dainippon Pharma Induced Pluripotent Stem Cells (iPSCs) Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Sumitomo Dainippon Pharma Main Business Overview
  11.3.5 Sumitomo Dainippon Pharma Latest Developments
11.4 Astellas Pharma Inc
  11.4.1 Astellas Pharma Inc Company Information
  11.4.2 Astellas Pharma Inc Induced Pluripotent Stem Cells (iPSCs) Product Offered
  11.4.3 Astellas Pharma Inc Induced Pluripotent Stem Cells (iPSCs) Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 Astellas Pharma Inc Main Business Overview
  11.4.5 Astellas Pharma Inc Latest Developments
11.5 Fate Therapeutics, Inc
  11.5.1 Fate Therapeutics, Inc Company Information
  11.5.2 Fate Therapeutics, Inc Induced Pluripotent Stem Cells (iPSCs) Product Offered
  11.5.3 Fate Therapeutics, Inc Induced Pluripotent Stem Cells (iPSCs) Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Fate Therapeutics, Inc Main Business Overview
  11.5.5 Fate Therapeutics, Inc Latest Developments
11.6 Pluricell Biotech
  11.6.1 Pluricell Biotech Company Information
  11.6.2 Pluricell Biotech Induced Pluripotent Stem Cells (iPSCs) Product Offered
  11.6.3 Pluricell Biotech Induced Pluripotent Stem Cells (iPSCs) Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 Pluricell Biotech Main Business Overview
  11.6.5 Pluricell Biotech Latest Developments
11.7 Cell Inspire Biotechnology
  11.7.1 Cell Inspire Biotechnology Company Information
  11.7.2 Cell Inspire Biotechnology Induced Pluripotent Stem Cells (iPSCs) Product Offered
  11.7.3 Cell Inspire Biotechnology Induced Pluripotent Stem Cells (iPSCs) Revenue, Gross Margin and Market Share (2020-2025)
  11.7.4 Cell Inspire Biotechnology Main Business Overview
  11.7.5 Cell Inspire Biotechnology Latest Developments
11.8 ReproCELL
  11.8.1 ReproCELL Company Information
  11.8.2 ReproCELL Induced Pluripotent Stem Cells (iPSCs) Product Offered
  11.8.3 ReproCELL Induced Pluripotent Stem Cells (iPSCs) Revenue, Gross Margin and Market Share (2020-2025)
  11.8.4 ReproCELL Main Business Overview
  11.8.5 ReproCELL Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION


LIST OFTABLES

Table 1. Induced Pluripotent Stem Cells (iPSCs) Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Induced Pluripotent Stem Cells (iPSCs) Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Human iPSCs
Table 4. Major Players of Mouse iPSCs
Table 5. Induced Pluripotent Stem Cells (iPSCs) Market Size CAGR byType (2020 VS 2024 VS 2031) & ($ millions)
Table 6. Global Induced Pluripotent Stem Cells (iPSCs) Market Size byType (2020-2025) & ($ millions)
Table 7. Global Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share byType (2020-2025)
Table 8. Induced Pluripotent Stem Cells (iPSCs) Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2020-2025) & ($ millions)
Table 10. Global Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Application (2020-2025)
Table 11. Global Induced Pluripotent Stem Cells (iPSCs) Revenue by Player (2020-2025) & ($ millions)
Table 12. Global Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Player (2020-2025)
Table 13. Induced Pluripotent Stem Cells (iPSCs) Key Players Head office and Products Offered
Table 14. Induced Pluripotent Stem Cells (iPSCs) Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Induced Pluripotent Stem Cells (iPSCs) Market Size by Region (2020-2025) & ($ millions)
Table 18. Global Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Region (2020-2025)
Table 19. Global Induced Pluripotent Stem Cells (iPSCs) Revenue by Country/Region (2020-2025) & ($ millions)
Table 20. Global Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Country/Region (2020-2025)
Table 21. Americas Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2020-2025) & ($ millions)
Table 22. Americas Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Country (2020-2025)
Table 23. Americas Induced Pluripotent Stem Cells (iPSCs) Market Size byType (2020-2025) & ($ millions)
Table 24. Americas Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share byType (2020-2025)
Table 25. Americas Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2020-2025) & ($ millions)
Table 26. Americas Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Application (2020-2025)
Table 27. APAC Induced Pluripotent Stem Cells (iPSCs) Market Size by Region (2020-2025) & ($ millions)
Table 28. APAC Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Region (2020-2025)
Table 29. APAC Induced Pluripotent Stem Cells (iPSCs) Market Size byType (2020-2025) & ($ millions)
Table 30. APAC Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2020-2025) & ($ millions)
Table 31. Europe Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2020-2025) & ($ millions)
Table 32. Europe Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Country (2020-2025)
Table 33. Europe Induced Pluripotent Stem Cells (iPSCs) Market Size byType (2020-2025) & ($ millions)
Table 34. Europe Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2020-2025) & ($ millions)
Table 35. Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size by Region (2020-2025) & ($ millions)
Table 36. Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size byType (2020-2025) & ($ millions)
Table 37. Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2020-2025) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Induced Pluripotent Stem Cells (iPSCs)
Table 39. Key Market Challenges & Risks of Induced Pluripotent Stem Cells (iPSCs)
Table 40. Key IndustryTrends of Induced Pluripotent Stem Cells (iPSCs)
Table 41. Global Induced Pluripotent Stem Cells (iPSCs) Market SizeForecast by Region (2026-2031) & ($ millions)
Table 42. Global Induced Pluripotent Stem Cells (iPSCs) Market Size Market ShareForecast by Region (2026-2031)
Table 43. Global Induced Pluripotent Stem Cells (iPSCs) Market SizeForecast byType (2026-2031) & ($ millions)
Table 44. Global Induced Pluripotent Stem Cells (iPSCs) Market SizeForecast by Application (2026-2031) & ($ millions)
Table 45.Fujifilm Holding Corporation (CDI) Details, CompanyType, Induced Pluripotent Stem Cells (iPSCs) Area Served and Its Competitors
Table 46.Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells (iPSCs) Product Offered
Table 47.Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells (iPSCs) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 48.Fujifilm Holding Corporation (CDI) Main Business
Table 49.Fujifilm Holding Corporation (CDI) Latest Developments
Table 50. Ncardia Details, CompanyType, Induced Pluripotent Stem Cells (iPSCs) Area Served and Its Competitors
Table 51. Ncardia Induced Pluripotent Stem Cells (iPSCs) Product Offered
Table 52. Ncardia Induced Pluripotent Stem Cells (iPSCs) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 53. Ncardia Main Business
Table 54. Ncardia Latest Developments
Table 55. Sumitomo Dainippon Pharma Details, CompanyType, Induced Pluripotent Stem Cells (iPSCs) Area Served and Its Competitors
Table 56. Sumitomo Dainippon Pharma Induced Pluripotent Stem Cells (iPSCs) Product Offered
Table 57. Sumitomo Dainippon Pharma Induced Pluripotent Stem Cells (iPSCs) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 58. Sumitomo Dainippon Pharma Main Business
Table 59. Sumitomo Dainippon Pharma Latest Developments
Table 60. Astellas Pharma Inc Details, CompanyType, Induced Pluripotent Stem Cells (iPSCs) Area Served and Its Competitors
Table 61. Astellas Pharma Inc Induced Pluripotent Stem Cells (iPSCs) Product Offered
Table 62. Astellas Pharma Inc Induced Pluripotent Stem Cells (iPSCs) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 63. Astellas Pharma Inc Main Business
Table 64. Astellas Pharma Inc Latest Developments
Table 65.FateTherapeutics, Inc Details, CompanyType, Induced Pluripotent Stem Cells (iPSCs) Area Served and Its Competitors
Table 66.FateTherapeutics, Inc Induced Pluripotent Stem Cells (iPSCs) Product Offered
Table 67.FateTherapeutics, Inc Induced Pluripotent Stem Cells (iPSCs) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 68.FateTherapeutics, Inc Main Business
Table 69.FateTherapeutics, Inc Latest Developments
Table 70. Pluricell Biotech Details, CompanyType, Induced Pluripotent Stem Cells (iPSCs) Area Served and Its Competitors
Table 71. Pluricell Biotech Induced Pluripotent Stem Cells (iPSCs) Product Offered
Table 72. Pluricell Biotech Induced Pluripotent Stem Cells (iPSCs) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 73. Pluricell Biotech Main Business
Table 74. Pluricell Biotech Latest Developments
Table 75. Cell Inspire Biotechnology Details, CompanyType, Induced Pluripotent Stem Cells (iPSCs) Area Served and Its Competitors
Table 76. Cell Inspire Biotechnology Induced Pluripotent Stem Cells (iPSCs) Product Offered
Table 77. Cell Inspire Biotechnology Induced Pluripotent Stem Cells (iPSCs) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 78. Cell Inspire Biotechnology Main Business
Table 79. Cell Inspire Biotechnology Latest Developments
Table 80. ReproCELL Details, CompanyType, Induced Pluripotent Stem Cells (iPSCs) Area Served and Its Competitors
Table 81. ReproCELL Induced Pluripotent Stem Cells (iPSCs) Product Offered
Table 82. ReproCELL Induced Pluripotent Stem Cells (iPSCs) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 83. ReproCELL Main Business
Table 84. ReproCELL Latest Developments



LIST OFFIGURES

Figure 1. Induced Pluripotent Stem Cells (iPSCs) Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Induced Pluripotent Stem Cells (iPSCs) Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Induced Pluripotent Stem Cells (iPSCs) Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Induced Pluripotent Stem Cells (iPSCs) Sales Market Share by Country/Region (2024)
Figure 8. Induced Pluripotent Stem Cells (iPSCs) Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share byType in 2024
Figure 10. Induced Pluripotent Stem Cells (iPSCs) in Academic Research
Figure 11. Global Induced Pluripotent Stem Cells (iPSCs) Market: Academic Research (2020-2025) & ($ millions)
Figure 12. Induced Pluripotent Stem Cells (iPSCs) in Drug Development and Discovery
Figure 13. Global Induced Pluripotent Stem Cells (iPSCs) Market: Drug Development and Discovery (2020-2025) & ($ millions)
Figure 14. Induced Pluripotent Stem Cells (iPSCs) inToxicity Screening
Figure 15. Global Induced Pluripotent Stem Cells (iPSCs) Market:Toxicity Screening (2020-2025) & ($ millions)
Figure 16. Induced Pluripotent Stem Cells (iPSCs) in Regenerative Medicine
Figure 17. Global Induced Pluripotent Stem Cells (iPSCs) Market: Regenerative Medicine (2020-2025) & ($ millions)
Figure 18. Induced Pluripotent Stem Cells (iPSCs) in Others
Figure 19. Global Induced Pluripotent Stem Cells (iPSCs) Market: Others (2020-2025) & ($ millions)
Figure 20. Global Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Application in 2024
Figure 21. Global Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Player in 2024
Figure 22. Global Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Region (2020-2025)
Figure 23. Americas Induced Pluripotent Stem Cells (iPSCs) Market Size 2020-2025 ($ millions)
Figure 24. APAC Induced Pluripotent Stem Cells (iPSCs) Market Size 2020-2025 ($ millions)
Figure 25. Europe Induced Pluripotent Stem Cells (iPSCs) Market Size 2020-2025 ($ millions)
Figure 26. Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size 2020-2025 ($ millions)
Figure 27. Americas Induced Pluripotent Stem Cells (iPSCs) Value Market Share by Country in 2024
Figure 28. United States Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2020-2025 ($ millions)
Figure 29. Canada Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2020-2025 ($ millions)
Figure 30. Mexico Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2020-2025 ($ millions)
Figure 31. Brazil Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2020-2025 ($ millions)
Figure 32. APAC Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Region in 2024
Figure 33. APAC Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share byType (2020-2025)
Figure 34. APAC Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Application (2020-2025)
Figure 35. China Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2020-2025 ($ millions)
Figure 36. Japan Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2020-2025 ($ millions)
Figure 37. South Korea Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2020-2025 ($ millions)
Figure 38. Southeast Asia Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2020-2025 ($ millions)
Figure 39. India Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2020-2025 ($ millions)
Figure 40. Australia Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2020-2025 ($ millions)
Figure 41. Europe Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Country in 2024
Figure 42. Europe Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share byType (2020-2025)
Figure 43. Europe Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Application (2020-2025)
Figure 44. Germany Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2020-2025 ($ millions)
Figure 45.France Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2020-2025 ($ millions)
Figure 46. UK Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2020-2025 ($ millions)
Figure 47. Italy Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2020-2025 ($ millions)
Figure 48. Russia Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2020-2025 ($ millions)
Figure 49. Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Region (2020-2025)
Figure 50. Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share byType (2020-2025)
Figure 51. Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Application (2020-2025)
Figure 52. Egypt Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2020-2025 ($ millions)
Figure 53. South Africa Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2020-2025 ($ millions)
Figure 54. Israel Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2020-2025 ($ millions)
Figure 55.Turkey Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2020-2025 ($ millions)
Figure 56. GCC Countries Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2020-2025 ($ millions)
Figure 57. Americas Induced Pluripotent Stem Cells (iPSCs) Market Size 2026-2031 ($ millions)
Figure 58. APAC Induced Pluripotent Stem Cells (iPSCs) Market Size 2026-2031 ($ millions)
Figure 59. Europe Induced Pluripotent Stem Cells (iPSCs) Market Size 2026-2031 ($ millions)
Figure 60. Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size 2026-2031 ($ millions)
Figure 61. United States Induced Pluripotent Stem Cells (iPSCs) Market Size 2026-2031 ($ millions)
Figure 62. Canada Induced Pluripotent Stem Cells (iPSCs) Market Size 2026-2031 ($ millions)
Figure 63. Mexico Induced Pluripotent Stem Cells (iPSCs) Market Size 2026-2031 ($ millions)
Figure 64. Brazil Induced Pluripotent Stem Cells (iPSCs) Market Size 2026-2031 ($ millions)
Figure 65. China Induced Pluripotent Stem Cells (iPSCs) Market Size 2026-2031 ($ millions)
Figure 66. Japan Induced Pluripotent Stem Cells (iPSCs) Market Size 2026-2031 ($ millions)
Figure 67. Korea Induced Pluripotent Stem Cells (iPSCs) Market Size 2026-2031 ($ millions)
Figure 68. Southeast Asia Induced Pluripotent Stem Cells (iPSCs) Market Size 2026-2031 ($ millions)
Figure 69. India Induced Pluripotent Stem Cells (iPSCs) Market Size 2026-2031 ($ millions)
Figure 70. Australia Induced Pluripotent Stem Cells (iPSCs) Market Size 2026-2031 ($ millions)
Figure 71. Germany Induced Pluripotent Stem Cells (iPSCs) Market Size 2026-2031 ($ millions)
Figure 72.France Induced Pluripotent Stem Cells (iPSCs) Market Size 2026-2031 ($ millions)
Figure 73. UK Induced Pluripotent Stem Cells (iPSCs) Market Size 2026-2031 ($ millions)
Figure 74. Italy Induced Pluripotent Stem Cells (iPSCs) Market Size 2026-2031 ($ millions)
Figure 75. Russia Induced Pluripotent Stem Cells (iPSCs) Market Size 2026-2031 ($ millions)
Figure 76. Egypt Induced Pluripotent Stem Cells (iPSCs) Market Size 2026-2031 ($ millions)
Figure 77. South Africa Induced Pluripotent Stem Cells (iPSCs) Market Size 2026-2031 ($ millions)
Figure 78. Israel Induced Pluripotent Stem Cells (iPSCs) Market Size 2026-2031 ($ millions)
Figure 79.Turkey Induced Pluripotent Stem Cells (iPSCs) Market Size 2026-2031 ($ millions)
Figure 80. Global Induced Pluripotent Stem Cells (iPSCs) Market Size Market ShareForecast byType (2026-2031)
Figure 81. Global Induced Pluripotent Stem Cells (iPSCs) Market Size Market ShareForecast by Application (2026-2031)
Figure 82. GCC Countries Induced Pluripotent Stem Cells (iPSCs) Market Size 2026-2031 ($ millions)